Get started
Author

Shelby A. Labe

Observed names: S. Labe, Shelby A Labe, Shelby Labe
Observed institutions: Brigham and Women's Hospital, Pennsylvania State University, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center
ORCID: 0000-0003-2006-3116
Observed ORCID: 0000-0003-2006-3116
OpenAlex ID: A5062311287
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer
2017 · David D. Yang, Brandon A. Mahal, et al. · European Urology Focus · 59
Receipt of definitive therapy in elderly patients with unfavorable‐risk prostate cancer
2017 · David D. Yang, Brandon A. Mahal, et al. · Cancer · 29
PDF
NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair
2018 · Peter V. Deraska, Colin O’Leary, et al. · Cell Death Discovery · 23
PDF
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance
2017 · David D. Yang, Brandon A. Mahal, et al. · Clinical Genitourinary Cancer · 22
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer
2017 · David D. Yang, Vinayak Muralidhar, et al. · International Journal of Radiation Oncology*Biology*Physics · 9
Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes
2022 · Shelby A. Labe, Xi Wang, et al. · Clinical Genitourinary Cancer · 5
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy
2017 · David D. Yang, Vinayak Muralidhar, et al. · Urologic Oncology Seminars and Original Investigations · 5
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer
2020 · David D. Yang, Vinayak Muralidhar, et al. · Urologic Oncology Seminars and Original Investigations · 4
D-CRSE: Diminishing chemotherapy-related side effects through patient education, a mixed-methods pilot study
2024 · Shelby Labe, Gavin Jones, et al. · Journal of Psychosocial Oncology · 2
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer.
2018 · David Dewei Yang, Vinayak Muralidhar, et al. · Journal of Clinical Oncology · 2
The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2022
2022 · Archer Kilbourne Martin, Jared W. Feinman, et al. · Journal of Cardiothoracic and Vascular Anesthesia · 1
Abstract 4287: Whole-genome CRISPR/Cas9 screen of the CHK1 inhibitor prexasertib implicates FAM122A loss as a potential resistance mechanism
2018 · Peter Deraska, Hunter Reavis, et al. · Cancer Research · 1
Abstract 4189: Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors
2017 · Peter V. Deraska, Hunter D. Reavis, et al. · Cancer Research · 1
D-CRSE: Diminishing chemotherapy related side effects through patient education.
2023 · Hannah Dailey, Shelby A. Labe, et al. · Journal of Clinical Oncology
PDF
Abstract OT3-06-01: Diminishing Chemotherapy Related Side Effects through Patient Education
2023 · Shelby Labe, Monali Vasekar, et al. · Cancer Research
Impact of Percent Positive Biopsy Cores on Cancer-Specific Mortality for Patients with High-Risk Prostate Cancer
2018 · D.D. Yang, V. Muralidhar, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Low Rates of Androgen Deprivation Therapy Use With Salvage Radiation Therapy in Prostate Cancer Patients After Radical Prostatectomy
2017 · D.D. Yang, V. Muralidhar, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Incidence and Predictors of Upgrading and Upstaging Among 10,000 Patients with Gleason 3+4 Favorable Intermediate-Risk Prostate Cancer: Implications for Active Surveillance
2017 · D.D. Yang, B.A. Mahal, et al. · International Journal of Radiation Oncology*Biology*Physics
National predictors and trends for androgen deprivation therapy use in low-risk prostate cancer.
2017 · David Yang, Vinayak Muralidhar, et al. · Journal of Clinical Oncology
Does Gut Flora Change in a Mouse Model of Autism Spectrum Disorders on a Ketogenic Diet
2016 · Shelby A. Labe · Trinity College Digital Repository (Trinity College, Hartford CT)
Works count: 20
Citation count: 163
H-index: 5
I10-index: 4
Year
Topic
Type